Reports in preclinical studies state that mTOR inhibition may promote differentiation of antiviral memory CD8 T cells [23,24], upregulate proinflammatory cytokines, downregulate anti-inflammatory cytokines, and boost major histocompatibility complex antigen presentation [25] effects that would be expected to contribute to reduced viral infection. Here, CD8A is linked to viral infectious disease.